Year-end Sale % OFF 
Abstract
Johnson & Johnson has teamed with India’s Institute of Microbial Technology (IMTECH) to develop new treatments for tuberculosis. The goal is safer, more effective, all-oral treatments for multi-drug-resistant TB, as well as TB drugs with novel mechanisms for all people with TB. Scientists from J&J and IMTECH will work together to tackle TB, which in 2015 killed nearly 500,000 people in India. In late 2012, J&J received approval for Sirturo, the first new TB treatment in 40 years.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
